{"id":71240,"date":"2025-12-29T15:55:41","date_gmt":"2025-12-29T06:55:41","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/nucleic-acid-therapeutics-contract-development-and-manufacturing-organization-market-mordor\/"},"modified":"2026-09-11T15:47:58","modified_gmt":"2026-09-11T06:47:58","slug":"nucleic-acid-therapeutics-contract-development-and-manufacturing-organization-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/nucleic-acid-therapeutics-contract-development-and-manufacturing-organization-market-mordor\/","title":{"rendered":"\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/nucleic-acid-therapeutics-contract-development-and-manufacturing-organization-market_1698403503607_13345.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/nucleic-acid-therapeutics-contract-development-and-manufacturing-organization-market-size-image-1735473135700.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u52d5\u5411<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u4fc3\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u6162\u6027\u75be\u60a3\u304a\u3088\u3073\u907a\u4f1d\u6027\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u305f\u3081\u306e\u6838\u9178\u6cbb\u7642\u85ac\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u9700\u8981\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u6838\u9178\u6cbb\u7642\u85ac\u88fd\u9020\u306e\u8907\u96d1\u3055\u3068\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u304a\u3088\u3073\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u88fd\u85acR&amp;D\u6295\u8cc7\u3068\u8cc7\u91d1\u8abf\u9054\u306e\u5897\u52a0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u6291\u5236\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u53b3\u683c\u306a\u653f\u5e9c\u898f\u5236<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u6838\u9178\u6cbb\u7642\u85ac\u958b\u767a\u306b\u304a\u3051\u308b\u5c02\u9580\u77e5\u8b58\u306e\u4e0d\u8db3<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 (\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 \u2013 \u7c73\u30c9\u30eb)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u88fd\u54c1\u30bf\u30a4\u30d7\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 mRNA\u6cbb\u7642<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u30d7\u30e9\u30b9\u30df\u30c9DNA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.6 siRNA\u6cbb\u7642<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u7528\u9014\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u816b\u760d\u5b66<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u907a\u4f1d\u6027\u75be\u60a3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u611f\u67d3\u75c7<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.4 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u653f\u5e9c\u30fb\u5b66\u8853\u7814\u7a76\u6a5f\u95a2<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.1 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.2 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.4 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.5 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.1 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.3 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u30d7\u30ed\u30d5\u30a3\u30fc\u30eb<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 \u30a2\u30b8\u30ec\u30f3\u30c8\u30fb\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 AGC\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 \u30a2\u30b7\u30e0\u30b1\u30e0\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 \u30d0\u30c3\u30d8\u30e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 \u30d0\u30a4\u30aa\u30b7\u30ca<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 CMIC\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 \u30c0\u30ca\u30cf\u30fc\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 \u30e6\u30fc\u30ed\u30d5\u30a3\u30f3\u30fb\u30b5\u30a4\u30a8\u30f3\u30c6\u30a3\u30d5\u30a3\u30c3\u30af<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 \u30ab\u30cd\u30ab\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 \u30e1\u30eb\u30afKGaA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.11 \u30b5\u30fc\u30e2\u30d5\u30a3\u30c3\u30b7\u30e3\u30fc\u30b5\u30a4\u30a8\u30f3\u30c6\u30a3\u30d5\u30a3\u30c3\u30af\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\u5229\u7528\u53ef\u80fd\u6027\u306b\u3088\u308b<\/div>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306b\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u307e\u3059\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u30ec\u30dd\u30fc\u30c82030\u306e\u6982\u8981\u3092\u4ee5\u4e0b\u306b\u307e\u3068\u3081\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6838\u9178\u533b\u85ac\u306e\u5951\u7d04\u958b\u767a\u88fd\u9020\u53d7\u8a17\u6a5f\u95a2\uff08CDMO\uff09\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u6210\u9577\u30c8\u30ec\u30f3\u30c9\u3001\u304a\u3088\u30732025\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u306b\u3064\u3044\u3066\u8a73\u7d30\u306b\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u8abf\u67fb\u671f\u9593\u306f2019\u5e74\u304b\u30892030\u5e74\u3067\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6982\u8981<br \/>\n\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u898f\u6a21\u306f\u30012025\u5e74\u306b\u306f49.2\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u306b\u306f89.1\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u4e2d\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f12.60%\u3067\u3059\u3002\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u306f\u5317\u7c73\u3067\u3042\u308a\u3001\u6700\u5927\u306e\u5e02\u5834\u306f\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u3059\u3002\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u306f\u4e2d\u7a0b\u5ea6\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u8981\u56e0<br \/>\n\u5e02\u5834\u306e\u6210\u9577\u306f\u3001\u4e3b\u306b\u4ee5\u4e0b\u306e\u8981\u56e0\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n1.  \u6838\u9178\u533b\u85ac\u958b\u767a\u3078\u306e\u6295\u8cc7\u5897\u52a0: \u6838\u9178\u533b\u85ac\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u6295\u8cc7\u304c\u6d3b\u767a\u5316\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u304cCDMO\u30b5\u30fc\u30d3\u30b9\u306e\u9700\u8981\u3092\u62bc\u3057\u4e0a\u3052\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Agilent Technologies Inc.\u306f\u3001\u6cbb\u7642\u7528\u6838\u9178\u306e\u88fd\u9020\u80fd\u529b\u3092\u62e1\u5927\u3059\u308b\u305f\u3081\u306b\u7d047\u51042500\u4e07\u7c73\u30c9\u30eb\u3092\u6295\u8cc7\u3059\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001Biovian\u306f2023\u5e747\u6708\u306b\u3001\u30d5\u30a3\u30f3\u30e9\u30f3\u30c9\u306e\u30c8\u30a5\u30eb\u30af\u306b\u3042\u308b\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u88fd\u9020\u65bd\u8a2d\u3092\u62e1\u5f35\u3059\u308b\u305f\u3081\u306b5000\u4e07\u30e6\u30fc\u30ed\uff08\u7d045270\u4e07\u7c73\u30c9\u30eb\uff09\u4ee5\u4e0a\u3092\u6295\u8cc7\u3059\u308b\u3068\u767a\u8868\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n2.  \u6838\u9178\u533b\u85ac\u88fd\u9020\u306e\u8907\u96d1\u6027: \u6838\u9178\u533b\u85ac\u306e\u88fd\u9020\u306f\u3001\u305d\u306e\u5206\u5b50\u306e\u8907\u96d1\u306a\u6027\u8cea\u3068\u3001\u9ad8\u7cbe\u5ea6\u304b\u3064\u9ad8\u54c1\u8cea\u306a\u751f\u7523\u304c\u6c42\u3081\u3089\u308c\u308b\u305f\u3081\u3001\u5c02\u9580\u77e5\u8b58\u304c\u5fc5\u8981\u3067\u3059\u3002mRNA\u3084\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u306e\u3088\u3046\u306a\u6838\u9178\u533b\u85ac\u306f\u3001\u7279\u5b9a\u306e\u914d\u5217\u306e\u7cbe\u5bc6\u306a\u5408\u6210\u3092\u5fc5\u8981\u3068\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\u3084\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u3092\u542b\u3080\u52b9\u679c\u7684\u306a\u30c7\u30ea\u30d0\u30ea\u30fc\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a\u3082\u3001\u6cbb\u7642\u85ac\u304c\u6a19\u7684\u7d30\u80de\u306b\u5230\u9054\u3059\u308b\u305f\u3081\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002CDMO\u306f\u3001\u3053\u308c\u3089\u306e\u8907\u96d1\u306a\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306b\u304a\u3044\u3066\u5c02\u9580\u77e5\u8b58\u3068\u8a2d\u5099\u3092\u63d0\u4f9b\u3057\u3001\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n3.  \u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u9593\u306e\u63d0\u643a\u30fb\u5354\u529b\u306e\u5897\u52a0: \u5e02\u5834\u53c2\u52a0\u8005\u9593\u306e\u6226\u7565\u7684\u306a\u63d0\u643a\u3084\u5354\u529b\u95a2\u4fc2\u304c\u5897\u52a0\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u304c\u5e02\u5834\u6210\u9577\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Charles River Laboratories International Inc.\u3068Rznomics Inc.\u306f2023\u5e741\u6708\u306b\u3001\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fcCDMO\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u767a\u8868\u3057\u3001Rznomics\u306fCharles River\u306e\u7d4c\u9a13\u3092\u6d3b\u7528\u3057\u3066RNA\u30d9\u30fc\u30b9\u306e\u304c\u3093\u6cbb\u7642\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u81e8\u5e8a\u958b\u767a\u3092\u958b\u59cb\u3057\u307e\u3059\u3002\u3055\u3089\u306b\u3001BACHEM\u306f2022\u5e7410\u6708\u30682022\u5e744\u6708\u306bEli Lilly and Company\u3068\u63d0\u643a\u3057\u3001\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u7531\u6765\u306e\u6d3b\u6027\u533b\u85ac\u54c1\u6210\u5206\u306e\u9769\u65b0\u3068\u751f\u7523\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6291\u5236\u8981\u56e0<br \/>\n\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u53b3\u683c\u306a\u898f\u5236\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068\u6838\u9178\u533b\u85ac\u306b\u304a\u3051\u308b\u5c02\u9580\u77e5\u8b58\u306e\u4e0d\u8db3\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u30b0\u30ed\u30fc\u30d0\u30eb\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>1. mRNA\u6cbb\u7642\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u8457\u3057\u3044\u6210\u9577<br \/>\nmRNA\u30d9\u30fc\u30b9\u306e\u6cbb\u7642\u85ac\u5206\u91ce\u306f\u3001\u611f\u67d3\u75c7\u3001\u304c\u3093\u3001\u907a\u4f1d\u6027\u75be\u60a3\u306a\u3069\u5e45\u5e83\u3044\u75be\u60a3\u3078\u306e\u5fdc\u7528\u304c\u671f\u5f85\u3055\u308c\u308b\u3053\u3068\u304b\u3089\u3001\u6ce8\u76ee\u3068\u6295\u8cc7\u304c\u6025\u5897\u3057\u3066\u3044\u307e\u3059\u3002mRNA\u6cbb\u7642\u85ac\u306f\u3001\u4e88\u9632\u30ef\u30af\u30c1\u30f3\u304b\u3089\u500b\u5225\u5316\u304c\u3093\u6cbb\u7642\u307e\u3067\u3001\u69d8\u3005\u306a\u7528\u9014\u306b\u5408\u308f\u305b\u3066\u8abf\u6574\u53ef\u80fd\u3067\u3059\u3002\u500b\u5225\u5316\u3055\u308c\u305fmRNA\u6cbb\u7642\u85ac\u306e\u88fd\u9020\u3068\u958b\u767a\u306f\u975e\u5e38\u306b\u8907\u96d1\u3067\u3042\u308a\u3001\u5c02\u9580\u77e5\u8b58\u3068\u5c02\u9580\u6280\u8853\u3092\u5fc5\u8981\u3068\u3059\u308b\u305f\u3081\u3001CDMO\u30b5\u30fc\u30d3\u30b9\u306e\u9700\u8981\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002CDMO\u306f\u3001mRNA\u751f\u7523\u306e\u72ec\u81ea\u306e\u30d7\u30ed\u30bb\u30b9\u8981\u4ef6\u3068\u8907\u96d1\u306a\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u3092\u52b9\u679c\u7684\u306b\u7ba1\u7406\u3057\u3001\u52b9\u7387\u306e\u5411\u4e0a\u3001\u30b3\u30b9\u30c8\u524a\u6e1b\u3001mRNA\u539f\u85ac\u304a\u3088\u3073mRNA-\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\uff08LNP\uff09\u88fd\u5264\u306e\u54c1\u8cea\u5411\u4e0a\u306b\u8ca2\u732e\u3057\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u652f\u3048\u308b\u8981\u56e0\u3068\u3057\u3066\u3001\u4ee5\u4e0b\u306e\u4f8b\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<br \/>\n*   \u6295\u8cc7\u306e\u4f8b: Vernal Biosciences\u306f2023\u5e747\u6708\u306b\u3001mRNA\u304a\u3088\u3073LNP\u88fd\u9020\u3092\u62e1\u5927\u3059\u308b\u305f\u3081\u306b\u30012000\u4e07\u7c73\u30c9\u30eb\u306e\u8cc7\u91d1\u8abf\u9054\u30e9\u30a6\u30f3\u30c9\u3092\u5b8c\u4e86\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002<br \/>\n*   \u63d0\u643a\u306e\u4f8b: Moderna\u3068Thermo Fisher\u306f2022\u5e742\u6708\u306b\u3001Moderna\u306eCOVID-19\u30ef\u30af\u30c1\u30f3\u3067\u3042\u308bSpikevax\u306e\u7c73\u56fd\u306b\u304a\u3051\u308b\u5927\u898f\u6a21\u88fd\u9020\u306b\u95a2\u3059\u308b15\u5e74\u9593\u306e\u6226\u7565\u7684\u63d0\u643a\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001AstraZeneca\u306f2023\u5e748\u6708\u306b\u3001\u4e2d\u56fd\u306eCDMO\u4f01\u696d\u3067\u3042\u308bCanSino Biologics\u3068\u65b0\u305f\u306amRNA\u88fd\u9020\u5951\u7d04\u3092\u7de0\u7d50\u3057\u3001CanSino\u306fmRNA\u88fd\u9020\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u6d3b\u7528\u3057\u3066AZ\u306emRNA\u30ef\u30af\u30c1\u30f3\u306e\u7814\u7a76\u958b\u767a\u3092\u652f\u63f4\u3057\u307e\u3059\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u3088\u308a\u3001mRNA\u6cbb\u7642\u30bb\u30b0\u30e1\u30f3\u30c8\u306f2024\u5e74\u304b\u30892029\u5e74\u306b\u304b\u3051\u3066\u8457\u3057\u3044\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>2. \u5317\u7c73\u5e02\u5834\u306e\u512a\u4f4d\u6027<br \/>\n\u5317\u7c73\u306f\u3001\u6838\u9178\u533b\u85ac\u306e\u751f\u7523\u306b\u304a\u3051\u308bCDMO\u6295\u8cc7\u306e\u5897\u52a0\u3001\u78ba\u7acb\u3055\u308c\u305f\u4f01\u696d\u3084\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u306e\u5b58\u5728\u3001\u304a\u3088\u3073FDA\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001\u4e16\u754c\u306e\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u3067\u6700\u5927\u306e\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5730\u57df\u5e02\u5834\u306e\u6210\u9577\u3092\u652f\u3048\u308b\u8981\u56e0\u3068\u3057\u3066\u3001\u4ee5\u4e0b\u306e\u4f8b\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<br \/>\n*   \u6295\u8cc7\u30fb\u8cc7\u91d1\u8abf\u9054\u306e\u4f8b: IMM\uff08VGXI\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\uff09\u306f2022\u5e748\u6708\u306b\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u4e88\u9632\u3092\u76ee\u7684\u3068\u3057\u305fDNA\u30ef\u30af\u30c1\u30f3\u306e\u7b2c1\u76f8\u81e8\u5e8a\u8a66\u9a13\u3092\u652f\u63f4\u3059\u308b\u305f\u3081\u3001\u7c73\u56fd\u56fd\u7acb\u885b\u751f\u7814\u7a76\u6240\uff08NIH\uff09\u304b\u30891200\u4e07\u7c73\u30c9\u30eb\u306e\u52a9\u6210\u91d1\u3092\u53d7\u3051\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002<br \/>\n*   \u6226\u7565\u7684\u6d3b\u52d5\uff08\u65bd\u8a2d\u62e1\u5f35\u306a\u3069\uff09\u306e\u4f8b: \u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642CDMO\u3067\u3042\u308buBriGene\u306f2023\u5e745\u6708\u306b\u3001NASDAQ\u4e0a\u5834\u4f01\u696dMustang Bio Inc.\u304b\u3089\u6700\u5148\u7aef\u306eGMP\u88fd\u9020\u65bd\u8a2d\u3092\u8cb7\u53ce\u3057\u3001\u7c73\u56fd\u5e02\u5834\u306b\u53c2\u5165\u3057\u307e\u3057\u305f\u3002\u540c\u69d8\u306b\u3001Charles River Laboratories International Inc.\u306f2022\u5e7411\u6708\u306b\u3001\u30c6\u30cd\u30b7\u30fc\u5dde\u30e1\u30f3\u30d5\u30a3\u30b9\u306b\u3042\u308b\u7d30\u80de\u6cbb\u7642CDMO\u65bd\u8a2d\u306e\u62e1\u5f35\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<br \/>\n*   \u63d0\u643a\u306e\u4f8b: Charles River Laboratories International Inc.\u3068Purespring Therapeutics\u306f2023\u5e742\u6708\u306b\u3001\u30d7\u30e9\u30b9\u30df\u30c9DNA CDMO\u63d0\u643a\u3092\u767a\u8868\u3057\u3001\u814e\u81d3\u75c5\u3092\u6a19\u7684\u3068\u3059\u308b\u521d\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u652f\u63f4\u3059\u308b\u3082\u306e\u3067\u3059\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u6295\u8cc7\u3068\u6226\u7565\u7684\u63d0\u643a\u306b\u3088\u308a\u3001\u5317\u7c73\u5e02\u5834\u306f2024\u5e74\u304b\u30892029\u5e74\u306b\u304b\u3051\u3066\u6210\u9577\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<br \/>\n\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u7af6\u4e89\u304c\u3042\u308a\u307e\u3059\u3002\u5e02\u5834\u53c2\u52a0\u8005\u306f\u3001\u30b5\u30fc\u30d3\u30b9\u306e\u62e1\u5927\u3001\u63d0\u643a\u30fb\u5354\u529b\u95a2\u4fc2\u306e\u69cb\u7bc9\u3001\u5408\u4f75\u30fb\u8cb7\u53ce\u306a\u3069\u3001\u69d8\u3005\u306a\u6226\u7565\u7684\u6d3b\u52d5\u306b\u5f93\u4e8b\u3057\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u306a\u30d7\u30ec\u30a4\u30e4\u30fc\u306b\u306f\u3001Agilent Technologies, Inc.\u3001AGC Biologics\u3001Asymchem Inc.\u3001BACHEM\u3001BioCina\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<br \/>\n*   2024\u5e743\u6708: CDMO\u3067\u3042\u308bAGC Biologics\u306f\u3001Orchard Therapeutics\u306eMLD\uff08\u7570\u67d3\u6027\u767d\u8cea\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\uff09\u907a\u4f1d\u5b50\u6cbb\u7642\u85acLenmeldy\uff08atidarsagene autotemcel\uff09\u306e\u5546\u696d\u88fd\u9020\u3092\u958b\u59cb\u3059\u308b\u305f\u3081\u3001\u30df\u30e9\u30ce\u62e0\u70b9\u304cFDA\u306e\u627f\u8a8d\u3092\u53d7\u3051\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e741\u6708: \u907a\u4f1d\u5b50\u6cbb\u7642\u3001DNA\u30ef\u30af\u30c1\u30f3\u3001RNA\u533b\u85ac\u54c1\u3092\u542b\u3080\u6838\u9178\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u306e\u958b\u767a\u30fb\u751f\u7523\u306b\u7279\u5316\u3057\u305fCDMO\u3067\u3042\u308bVGXI Inc.\u306f\u3001Resilience\u3068\u306e\u5354\u529b\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7de0\u7d50\u3057\u3001Resilience\u306e\u5148\u9032\u6cbb\u7642\u88fd\u9020\u306e\u53d6\u308a\u7d44\u307f\u3092\u652f\u63f4\u3059\u308b\u4fe1\u983c\u3067\u304d\u308b\u30d7\u30e9\u30b9\u30df\u30c9DNA\u88fd\u9020\u696d\u8005\u3068\u3057\u3066\u6d3b\u52d5\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6838\u9178\u533b\u85acCDMO\uff08Contract Development And Manufacturing Organization\uff09\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u3068\u306f\u3001\u6838\u9178\u533b\u85ac\u306e\u88fd\u9020\u306b\u95a2\u3057\u3066CDMO\u4f01\u696d\u304c\u63d0\u4f9b\u3059\u308b\u88fd\u54c1\u304a\u3088\u3073\u30b5\u30fc\u30d3\u30b9\u3092\u6307\u3057\u3001\u3053\u308c\u3089\u306e\u533b\u85ac\u306fCDMO\u4f01\u696d\u307e\u305f\u306f\u88fd\u85ac\u4f01\u696d\u306b\u3088\u3063\u3066\u88fd\u9020\u3055\u308c\u308b\u3082\u306e\u3067\u3059\u3002\u672c\u8abf\u67fb\u3067\u306f\u3001\u5e02\u5834\u306e\u4eee\u5b9a\u3001\u5b9a\u7fa9\u3001\u304a\u3088\u3073\u8abf\u67fb\u7bc4\u56f2\u304c\u660e\u78ba\u306b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u52d5\u5411\u3068\u3057\u3066\u306f\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u63a8\u9032\u8981\u56e0\u304c\u78ba\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u3001\u6162\u6027\u75be\u60a3\u3084\u907a\u4f1d\u6027\u75be\u60a3\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u6838\u9178\u533b\u85ac\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u9700\u8981\u304c\u4e16\u754c\u7684\u306b\u5897\u52a0\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u3001\u5e02\u5834\u6210\u9577\u306e\u5927\u304d\u306a\u539f\u52d5\u529b\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u6838\u9178\u533b\u85ac\u88fd\u9020\u306e\u8907\u96d1\u6027\u304c\u5897\u3057\u3066\u3044\u308b\u3053\u3068\u3001\u305d\u308c\u306b\u4f34\u3046\u696d\u754c\u5185\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3084\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5897\u52a0\u3082\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u88fd\u85ac\u5206\u91ce\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u6295\u8cc7\u304a\u3088\u3073\u8cc7\u91d1\u8abf\u9054\u306e\u5897\u52a0\u3082\u3001\u5e02\u5834\u306e\u62e1\u5927\u3092\u5f8c\u62bc\u3057\u3059\u308b\u91cd\u8981\u306a\u8981\u7d20\u3067\u3059\u3002<br \/>\n\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306b\u306f\u6291\u5236\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u53b3\u683c\u306a\u653f\u5e9c\u898f\u5236\u3084\u3001\u6838\u9178\u533b\u85ac\u958b\u767a\u306b\u304a\u3051\u308b\u5c02\u9580\u77e5\u8b58\u306e\u4e0d\u8db3\u304c\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u963b\u5bb3\u3059\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u8ab2\u984c\u3068\u3057\u3066\u6319\u3052\u3089\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u7af6\u4e89\u74b0\u5883\u3092\u5206\u6790\u3059\u308b\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u3082\u5b9f\u65bd\u3055\u308c\u3066\u304a\u308a\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01\u3001\u4ee3\u66ff\u88fd\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3063\u305f\u5074\u9762\u304b\u3089\u5e02\u5834\u69cb\u9020\u304c\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306f\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u3001\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u3001\u304a\u3088\u3073\u5730\u57df\u306b\u3088\u3063\u3066\u8a73\u7d30\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u88fd\u54c1\u30bf\u30a4\u30d7\u5225\u3067\u306f\u3001\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u3001mRNA\u6cbb\u7642\u3001\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u30ef\u30af\u30c1\u30f3\u3001\u30d7\u30e9\u30b9\u30df\u30c9DNA\u3001\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u3001siRNA\u6cbb\u7642\u3068\u3044\u3063\u305f\u591a\u69d8\u306a\u88fd\u54c1\u304c\u542b\u307e\u308c\u307e\u3059\u3002<br \/>\n\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u5225\u3067\u306f\u3001\u816b\u760d\u5b66\u3001\u907a\u4f1d\u6027\u75be\u60a3\u3001\u611f\u67d3\u75c7\u3001\u305d\u306e\u4ed6\u3068\u3044\u3063\u305f\u4e3b\u8981\u306a\u6cbb\u7642\u9818\u57df\u306b\u5206\u985e\u3055\u308c\u307e\u3059\u3002<br \/>\n\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u3067\u306f\u3001\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3001\u653f\u5e9c\u30fb\u5b66\u8853\u7814\u7a76\u6a5f\u95a2\u304c\u4e3b\u8981\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3068\u3057\u3066\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u6b27\u5dde\uff08\u82f1\u56fd\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30b9\u30da\u30a4\u30f3\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u305d\u306e\u4ed6\u6b27\u5dde\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u30a4\u30f3\u30c9\u3001\u65e5\u672c\u3001\u4e2d\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u3001\u305d\u306e\u4ed6\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\uff08GCC\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u3001\u305d\u306e\u4ed6\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u3001\u305d\u306e\u4ed6\u5357\u7c73\uff09\u3068\u3044\u3063\u305f\u5e83\u7bc4\u306a\u5730\u7406\u7684\u7bc4\u56f2\u304c\u5bfe\u8c61\u3068\u3055\u308c\u3001\u7279\u306b\u4e3b\u898117\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u4e88\u6e2c\u3068\u3057\u3066\u30012024\u5e74\u306b\u306f\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u306f43.0\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u30022025\u5e74\u306b\u306f49.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012025\u5e74\u304b\u30892030\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3044\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0912.60%\u3067\u6210\u9577\u3057\u30012030\u5e74\u306b\u306f89.1\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u5730\u57df\u5225\u306b\u898b\u308b\u3068\u30012025\u5e74\u304b\u30892030\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3044\u3066\u3001\u5317\u7c73\u304c\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u30012025\u5e74\u6642\u70b9\u3067\u306f\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u306b\u304a\u3044\u3066\u306f\u3001Agilent Technologies Inc.\u3001AGC Biologics\u3001Asymchem Inc.\u3001BACHEM\u3001BioCina\u3001CMIC HOLDINGS Co. Ltd\u3001Danaher Corporation\u3001Eurofins Scientific\u3001Kaneka Corporation\u3001Merck KGaA\u3001Thermo Fisher Scientific Inc.\u306a\u3069\u304c\u4e3b\u8981\u306a\u4f01\u696d\u3068\u3057\u3066\u6319\u3052\u3089\u308c\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306e\u4f01\u696d\u306e\u30d3\u30b8\u30cd\u30b9\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u6700\u8fd1\u306e\u52d5\u5411\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6838\u9178\u533b\u85acCDMO\u5e02\u5834\u306b\u304a\u3051\u308b\u5c06\u6765\u306e\u6a5f\u4f1a\u3068\u30c8\u30ec\u30f3\u30c9\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3057\u3066\u304a\u308a\u3001\u5e02\u5834\u53c2\u52a0\u8005\u304c\u6226\u7565\u7684\u306a\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u4e0a\u3067\u4e0d\u53ef\u6b20\u306a\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/71240"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=71240"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/71240\/revisions"}],"predecessor-version":[{"id":71243,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/71240\/revisions\/71243"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=71240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=71240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=71240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}